Financial Contrast: Arena Pharmaceuticals


Arena Pharmaceuticals and Sunesis Pharmaceuticals are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership. Arena Pharmaceuticals has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.



from Biotech News